Veriskin Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series 1

  • Investors
  • 13

Veriskin General Information

Description

Developer of a handheld device designed to offer non-invasive skin cancer diagnosis. The company's device determines if a suspect skin growth is cancerous and also provides a non-subjective assessment of suspect skin regions by non-specialist frontline caregivers, enabling caregivers to detect cancer in patients at an early and treatable stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10211 Pacific Mesa Boulevard
  • Suite 404
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 10211 Pacific Mesa Boulevard
  • Suite 404
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veriskin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 10-Nov-2022 Completed Generating Revenue
7. Grant 22-Sep-2021 Completed Generating Revenue
6. Seed Round 09-Nov-2020 Completed Generating Revenue
5. Accelerator/Incubator 28-May-2020 Completed Generating Revenue
4. Grant 15-Mar-2020 Completed Generating Revenue
3. Grant 01-Mar-2020 Completed Generating Revenue
2. Angel (individual) 13-Apr-2017 Completed Generating Revenue
1. Grant 01-May-2016 $1.88M Completed Startup
To view Veriskin’s complete valuation and funding history, request access »

Veriskin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
To view Veriskin’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Veriskin Patents

Veriskin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180146866-A1 Cutaneous blood flow monitoring device Inactive 15-May-2015
WO-2016187136-A1 Cutaneous blood flow monitoring device Inactive 15-May-2015
AU-2014360173-A1 Skin perfusion monitoring device Active 05-Dec-2013
AU-2014360173-B2 Skin perfusion monitoring device Active 05-Dec-2013
CA-2965866-A1 Skin perfusion monitoring device Active 05-Dec-2013 A61B5/0261
To view Veriskin’s complete patent history, request access »

Veriskin Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anvaya Ventures Venture Capital Minority
Ariel Savannah Angel Partners Angel Group Minority
Arizona Tech Investors Angel Group Minority
Digilife Venture Capital Minority
Frontier Angels Angel Group Minority
You’re viewing 5 of 13 investors. Get the full list »

Veriskin FAQs

  • When was Veriskin founded?

    Veriskin was founded in 2013.

  • Where is Veriskin headquartered?

    Veriskin is headquartered in San Diego, CA.

  • What industry is Veriskin in?

    Veriskin’s primary industry is Diagnostic Equipment.

  • Is Veriskin a private or public company?

    Veriskin is a Private company.

  • What is Veriskin’s current revenue?

    The current revenue for Veriskin is .

  • How much funding has Veriskin raised over time?

    Veriskin has raised $682K.

  • Who are Veriskin’s investors?

    Anvaya Ventures, Ariel Savannah Angel Partners, Arizona Tech Investors, Digilife, and Frontier Angels are 5 of 13 investors who have invested in Veriskin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process